Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma
Top Cited Papers
- 4 May 2017
- journal article
- clinical trial
- Published by American Society of Hematology in Blood
- Vol. 129 (18), 2471-2478
- https://doi.org/10.1182/blood-2016-11-749556
Abstract
Key Points: PD-1 blockade with nivolumab provides durable disease control after allo-HCT. PD-1 blockade with nivolumab after allo-HCT is associated with 30% acute GVHD.Keywords
This publication has 25 references indexed in Scilit:
- Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin FailureJournal of Clinical Oncology, 2016
- Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donorsBlood, 2016
- Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma: a systematic review and meta-analysisBone Marrow Transplantation, 2016
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's LymphomaNew England Journal of Medicine, 2015
- Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin’s lymphomaBone Marrow Transplantation, 2013
- Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethalityBlood, 2013
- Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationHaematologica, 2011
- CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantationBlood, 2009
- Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin LymphomaTransplantation and Cellular Therapy, 2008
- Blockade of Programmed Death-1 Engagement Accelerates Graft-Versus-Host Disease Lethality by an IFN-γ-Dependent MechanismThe Journal of Immunology, 2003